Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial

Table 2

Mean %EWL and %TWL at 12, 15, and 18 months in ITT population.

Measure; Visit month	Mean (95% CI)		Difference; (95% CI)
	vBloc	Sham control
	%EWL
12 months	25.8 (23.2, 28.4)	16.9 (13.1, 20.7)	8.9 (4.3, 13.5)
15 months	24.4 (21.7, 27.2)	12.9 (9.0, 16.9)	11.5 (6.7, 16.3)
18 months	23.5 (20.8, 26.3)	10.2 (6.0, 14.4)	13.4 (8.4, 18.4)
%TWL
12 months	9.7 (8.7, 10.7)	6.4 (4.9, 7.8)	3.3 (1.6, 5.0)
15 months	9.1 (8.1, 10.1)	4.9 (3.4, 6.4)	4.2 (2.4, 6.0)
18 months	8.8 (7.8, 9.8)	3.8 (2.2, 5.4)	5.0 (3.1, 6.9)